Showing results (381-390 of 6,760) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|August 22, 2009
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patientsLi Zhou, Fanyi Meng, Ophelia Yin, et al.Clinical Therapeutics|August 22, 2009
Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelinesSanjeev BaluClinical Therapeutics|August 22, 2009
Lost in translation: differences in antimicrobial indication approval policies between the United States and EuropeGeorgios Pappas, Vrettos Ierodiakonou, Matthew E FalagasClinical Therapeutics|August 22, 2009
Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: assessment of adherence to published treatment guidelinesSaqib A Gowani, Sana Shoukat, Ather M Taqui, et al.Clinical Therapeutics|May 1, 1990
Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizersJ Sasaki, Y Takada, K Handa, et al.Clinical Therapeutics|August 25, 2009
Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorderRichard Perry, Manouchkathe CassagnolClinical Therapeutics|August 25, 2009
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studiesKaren A Tourian, S Krishna Padmanabhan, James Groark, et al.Clinical Therapeutics|August 25, 2009
Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medicationDiana Rofail, Rebecca Heelis, Kevin GournayClinical Therapeutics|March 15, 2011
Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative studyMichel Farnier, Armin Steinmetz, Kjetil Retterstøl, et al.Clinical Therapeutics|March 1, 1990
Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasmD G Borenstein, S Lacks, S W WieselPageof 676